Yamamoto Ryoji, Tada Hirohito, Kishi Akihiro, Tojo Takashi, Asada Hiroki
Division of Pulmonary Surgery, Osaka City Medical Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-ku, Osaka 534-0004, Japan.
Jpn J Thorac Cardiovasc Surg. 2002 Jan;50(1):1-5. doi: 10.1007/BF02913479.
Combined esophago-airway stenosis and/or esophago-airway fistula due to malignancy bodes a dismal prognosis. We describe our work with double stents for combined esophago-airway lesions.
Between February 1994 and July 2000, we treated 11 patients using double stents--the Dumon stent for the airway and the covered Ultraflex for the esophagus. Double stenting was necessitated by combined esophago-airway stenosis in 8 patients and fistulas in 3, of these, 6 had lung cancer and 5 esophageal cancer.
In all but 1 ventilator-dependent patient, dyspnea and dysphagia were significantly reduced and fistula was successfully closed after double stenting. This palliation effectively continued more than 1 month in 5 patients, more than 2 months in 3, and more than 3 months in 2. Mean survival was 64 days (range: 9 to 148 days). Life-threatening complications developed in 5 (45%)--massive bleeding in 3 and uncontrollable esophago-airway fistula in 2. All 5 had received prior radiation.
Although patients who received radiation frequently had life-threatening complications after double stenting, this procedure improved the quality of life in patients with esophago-airway stenosis or fistulas due to lung or esophageal cancer.
恶性肿瘤导致的食管气道联合狭窄和/或食管气道瘘预后不佳。我们描述了我们使用双支架治疗食管气道联合病变的工作。
1994年2月至2000年7月期间,我们对11例患者使用双支架治疗——气道使用杜蒙支架,食管使用覆膜超弹性支架。8例患者因食管气道联合狭窄需要双支架置入,3例因瘘管需要置入,其中6例患有肺癌,5例患有食管癌。
除1例依赖呼吸机的患者外,所有患者在双支架置入后呼吸困难和吞咽困难均显著减轻,瘘管成功闭合。5例患者的这种缓解有效地持续了1个月以上,3例持续了2个月以上,2例持续了3个月以上。平均生存期为64天(范围:9至148天)。5例(45%)出现危及生命的并发症——3例大出血,2例食管气道瘘无法控制。所有5例患者之前都接受过放疗。
尽管接受放疗的患者在双支架置入后经常出现危及生命的并发症,但该手术改善了因肺癌或食管癌导致食管气道狭窄或瘘管患者的生活质量。